Paul J. Clancy

2013

In 2013, Paul J. Clancy earned a total compensation of $4.5M as EVP, Chief Financial Officer at Biogen, a 22% increase compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$27,771
Non-Equity Incentive Plan$683,258
Salary$745,223
Stock Awards$2,808,961
Other$221,043
Total$4,486,256

Clancy received $2.8M in stock awards, accounting for 63% of the total pay in 2013.

Clancy also received $27.8K of change in pension value and nonqualified deferred compensation earnings, $683.3K in non-equity incentive plan, $745.2K in salary and $221K in other compensation.

Rankings

In 2013, Paul J. Clancy's compensation ranked 1,478th out of 12,286 executives tracked by ExecPay. In other words, Clancy earned more than 88.0% of executives.

ClassificationRankingPercentile
All
1,478
out of 12,286
88th
Division
Manufacturing
477
out of 4,612
90th
Major group
Chemicals And Allied Products
128
out of 1,466
91st
Industry group
Drugs
86
out of 1,160
93rd
Industry
Biological Products, Except Diagnostic Substances
9
out of 200
96th
Source: SEC filing on April 15, 2016.

Clancy's colleagues

We found five more compensation records of executives who worked with Paul J. Clancy at Biogen in 2013.

2013

George Scangos

Biogen

Chief Executive Officer

2013

Douglas Williams

Biogen

Former EVP, Research and Development

2013

Raymond Pawlicki

Biogen

Former SVP, Chief Information Officer

2013

Stuart Kingsley

Biogen

Former EVP, Global Operations

2013

John Cox

Biogen

EVP, Pharmaceutical Operations and Technology

You may also like